Immunotherapy use outside clinical trial populations: never say never?

por Rzeniewicz, K., Larkin, J., Menzies, A.M., Turajlic, S.
Publicado 2021

Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

por Menzies, A M, Wilmott, J S, Long, G V, Scolyer, R A
Publicado 2014

Cutaneous sarcoidosis due to immune‐checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor

por Pham, J. P., Star, P., Wong, S., Damian, D. L., Saw, R. P. M., Whitfeld, M. J., Menzies, A. M., Joshua, A. M., Smith, A.
Publicado 2021

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma

por Wilmott, J S, Menzies, A M, Haydu, L E, Capper, D, Preusser, M, Zhang, Y E, Thompson, J F, Kefford, R F, von Deimling, A, Scolyer, R A, Long, G V
Publicado 2013

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma

por Carlino, M S, Haydu, L E, Kakavand, H, Menzies, A M, Hamilton, A L, Yu, B, Ng, C C, Cooper, W A, Thompson, J F, Kefford, R F, O'Toole, S A, Scolyer, R A, Long, G V
Publicado 2014

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

por Lee, J H, Saw, R P, Thompson, J F, Lo, S, Spillane, A J, Shannon, K F, Stretch, J R, Howle, J, Menzies, A M, Carlino, M S, Kefford, R F, Long, G V, Scolyer, R A, Rizos, H
Publicado 2019

Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections

por Schmitt, C., Hoefsmit, E. P., Fangmeier, T., Kramer, N., Kabakci, C., Vera González, J., Versluis, J. M., Compter, A., Harrer, T., Mijočević, H., Schubert, S., Hundsberger, T., Menzies, A. M., Scolyer, R. A., Long, G. V., French, L. E., Blank, C. U., Heinzerling, L. M.
Publicado 2023

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey

por Linardou, H., Adjei, A.A., Bajpai, J., Banerjee, S., Berghoff, A.S., Mathias, C. Cerqueira, Choo, S.P., Dent, R., Felip, E., Furness, A.J.S., Garassino, M.C., Garralda, E., Konsoulova-Kirova, A., Letsch, A., Menzies, A.M., Mukherji, D., Peters, S., Sessa, C., Tsang, J., Yang, J.C.-H., Garrido, P.
Publicado 2023

Mucosal‐associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy‐related colitis in a patholog...

por Sasson, S. C., Zaunders, J. J., Nahar, K., Munier, C. M. L., Fairfax, B. P., Olsson‐Brown, A., Jolly, C., Read, S. A., Ahlenstiel, G., Palendira, U., Scolyer, R. A., Carlino, M. S., Payne, M. J., Cheung, V. T. F., Gupta, T., Klenerman, P., Long, G. V., Brain, O., Menzies, A. M., Kelleher, A. D.
Publicado 2020